Literature DB >> 11752661

Signal integration via PKR.

B R Williams1.   

Abstract

The vital role of interferons (IFNs) as mediators of innate immunity is well established. It has recently become apparent that one of the pivotal proteins in mediating the antiviral activity of IFNs, the double-stranded RNA (dsRNA)-activated protein kinase (PKR), also functions as a signal transducer in the proinflammatory response to different agents. PKR is a member of a small family of kinases that are activated by extracellular stresses and that phosphorylate the alpha subunit of protein synthesis initiation factor eIF-2, thereby inhibiting protein synthesis. The activation of PKR during infection by viral dsRNA intermediates results in the inhibition of viral replication. PKR also mediates the activation of signal transduction pathways by proinflammatory stimuli, including bacterial lipopolysaccharide (LPS), tumor necrosis factor alpha (TNF-alpha), and interleukin 1 (IL-1). PKR is a component of the inhibitor of kappaB (IkappaB) kinase complex and plays either a catalytic or structural role in the activation of IkappaB kinase, depending on the stimulus. The activities of the stress-activated protein kinases p38 and c-Jun NH(2)-terminal kinase (JNK) are also regulated by PKR in a pathway that leads to the production of proinflammatory cytokines. This review will focus on the role of PKR in nuclear factor kappa B (NF-kappaB) and mitogen-activated protein kinase (MAPK) pathways, because these have been the subjects of a series of publications over the past year that have reported conflicting findings. Although the conflicts may not be resolved in this review, suggestions are made for experiments that could lead to a clearer understanding of the mechanisms involved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11752661     DOI: 10.1126/stke.2001.89.re2

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  175 in total

1.  The protein kinase PKR: a molecular clock that sequentially activates survival and death programs.

Authors:  Olivier Donzé; Jing Deng; Joseph Curran; Robert Sladek; Didier Picard; Nahum Sonenberg
Journal:  EMBO J       Date:  2004-01-29       Impact factor: 11.598

Review 2.  Induction of RNA interference in dendritic cells.

Authors:  Mu Li; Hua Qian; Thomas E Ichim; Wei-Wen Ge; Igor A Popov; Katarzyna Rycerz; John Neu; David White; Robert Zhong; Wei-Ping Min
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 3.  Biological significance of RNA editing in cells.

Authors:  Wei Tang; Yongjun Fei; Michael Page
Journal:  Mol Biotechnol       Date:  2012-09       Impact factor: 2.695

4.  DHX9 pairs with IPS-1 to sense double-stranded RNA in myeloid dendritic cells.

Authors:  Zhiqiang Zhang; Bin Yuan; Ning Lu; Valeria Facchinetti; Yong-Jun Liu
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

5.  Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons.

Authors:  Ju-Tao Guo; Qing Zhu; Christoph Seeger
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 6.  Mechanisms of deoxynivalenol-induced gene expression and apoptosis.

Authors:  J J Pestka
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2008-09

Review 7.  PKR-dependent inflammatory signals.

Authors:  Rui Kang; Daolin Tang
Journal:  Sci Signal       Date:  2012-10-23       Impact factor: 8.192

Review 8.  ROS signaling and ER stress in cardiovascular disease.

Authors:  Cristhiaan D Ochoa; Ru Feng Wu; Lance S Terada
Journal:  Mol Aspects Med       Date:  2018-03-22

9.  Coxiella burnetii Requires Host Eukaryotic Initiation Factor 2α Activity for Efficient Intracellular Replication.

Authors:  Katelynn R Brann; Marissa S Fullerton; Daniel E Voth
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

10.  Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection.

Authors:  Yongzhan Nie; Graeme L Hammond; Jing-Hua Yang
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.